Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Drug Dev Res. 2013 Dec 26;75(1):10–22. doi: 10.1002/ddr.21162

Fig. 10.

Fig. 10

Estimated time course of δ-tocoflexol plasma concentration, as compared to the α-tocopherol and γ-tocotrienol plasma concentrations that would occur for equal oral doses of each compound. The δ-tocoflexol curve is based on a half-life estimated to be 38% of that of α-tocopherol and an oral bioavailability F estimated to be midway between α-tocopherol and γ-tocotrienol.